On August 6, 2020, the U.S. Department of Health and Human Services (HHS) announced that it will continue to expand access to pre-exposure prophylaxis (PrEP) HIV prevention medications at no cost to eligible individuals without prescription drug coverage. The expansion is through a $4 million contract with TrialCard for one year with four one-year option periods.

The contract is intended to support Ready, Set, PrEP, a key component of the “Ending the HIV Epidemic: A Plan for America” (EHE) initiative. EHE aims to reduce the number of new HIV infections in the United States by 75% by . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Market Watch

A snapshot of what’s happening across the industry—a one-stop source for key developments across policy and regulatory changes, service and treatment innovations, technological advancements, industry recognition and accreditation, mergers and acquisitions, leadership shifts, and more.

Filter Options

  • By Categories
  • By Date Range
  • Sort Date By
  • Results Per Page
Clear Filters

  • This field is for validation purposes and should be left unchanged.
  • Max. file size: 98 MB.